Clinical Trials

Roche said that the phase 3 PEMPHIX trial of MabThera (rituximab) in moderate to severe pemphigus vulgaris (PV) met its primary endpoint at Week 52. The PEMPHIX trial also showed that MabThera was superior to mycophenolate mofetil (MMF) in the...

Health Gorilla, a leader in clinical data APIs, and WellVia, a premier telehealth company, announced a partnership that enables new data exchange capabilities within the WellVia telehealth platform. WellVia will utilize Health Gorilla's FHIR APIs to equip healthcare providers...

Replimune Group Inc. , a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, announced that the first patient has been enrolled in its registration-directed, randomized, controlled Phase 2 clinical trial of RP1 in combination with Regeneron...

Though academic medical centers (AMCs) may differ widely—public vs private, city vs rural, and system infrastructure and resource variations—they generally share the same tripartite mission: research, medical education, and patient care. Yet, increasingly, complex clinical research systems and processes...

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to improve world health, from Clinical through to Commercialization, announced it has formed alliances with three prominent healthcare institutions. PKUCare Luzhong Hospital, West...

Sharp - part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Wholesale Distribution Authorisation (WDA) and Investigational Medicinal Product (IMP) licensing approvals to support clinical activities from its facility in Heerenveen,...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, announced it is to invest $9 million in a new clinical supply facility in San Diego, due...